CompoAtlas

GOLD PINE BRAND BAK FONG (PIL KECIL)

GOLD PINE BRAND BAK FONG (PIL KECIL) : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Cordyceps sinensisCordyceps sinensis[140;mg;8;g]Not identified
SALVIA CHINENSISSALVIA CHINENSIS[360;mg;8;g]Not identified
Rhizoma Gastrodiae ElataRhizoma Gastrodiae Elata[260;mg;8;g]Not identified
Rhizoma Cyperus Rotundus.Rhizoma Cyperus Rotundus.[780;mg;8;g]Not identified
RADIX REHMANNIAE GLUTINOSARADIX REHMANNIAE GLUTINOSA[540;mg;8;g]Not identified
Paeonia albaPaeonia alba[640;mg;8;g]Not identified
radix astragalus membranaceusradix astragalus membranaceus[400;mg;8;g]Not identified
RADIX ANGELICAE SINENSIS EXTRACTRADIX ANGELICAE SINENSIS EXTRACT[540;mg;8;g]Not identified
OOTHECA TENADERA ARIDIFOJIA STELLOOTHECA TENADERA ARIDIFOJIA STELL[340;mg;8;g]Not identified
HERBA LEONURUS SIBIRICUSHERBA LEONURUS SIBIRICUS[380;mg;8;g]Not identified
EQUUS ASINUS L.EQUUS ASINUS L.[240;mg;8;g]Not identified
radix panax ginsenradix panax ginsen[200;mg;8;g]Not identified
Rhizoma Dioscorea JaponicaRhizoma Dioscorea Japonica[940;mg;8;g]Not identified
Rhizoma Conioselinum UnivittatumRhizoma Conioselinum Univittatum[540;mg;8;g]Not identified
Folium Artemisia VulgarisFolium Artemisia Vulgaris[300;mg;8;g]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL06021358T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
TJ-TYT PHARMACEUTICALS (M) SDN. BHD.
Manufacturer
TJ-TYT PHARMACEUTICALS (M) SDN. BHD.
Registration period starting
2026-06-05
Published validity end
2031-06-05

Original register data

View published fields and their variants
Active ingredients
Cordyceps sinensis[140;mg;8;g],SALVIA CHINENSIS[360;mg;8;g],Rhizoma Gastrodiae Elata[260;mg;8;g],Rhizoma Cyperus Rotundus.[780;mg;8;g],RADIX REHMANNIAE GLUTINOSA[540;mg;8;g],Paeonia alba[640;mg;8;g],radix astragalus membranaceus[400;mg;8;g],RADIX ANGELICAE SINENSIS EXTRACT[540;mg;8;g],OOTHECA TENADERA ARIDIFOJIA STELL[340;mg;8;g],HERBA LEONURUS SIBIRICUS[380;mg;8;g],EQUUS ASINUS L.[240;mg;8;g],radix panax ginsen[200;mg;8;g],Rhizoma Dioscorea Japonica[940;mg;8;g],Rhizoma Conioselinum Univittatum[540;mg;8;g],Folium Artemisia Vulgaris[300;mg;8;g]
Valid until
2031-06-05
Registration date
2026-06-05
Published description
NATURAL PRODUCT
Licence holder
TJ-TYT PHARMACEUTICALS (M) SDN. BHD.
Producer
TJ-TYT PHARMACEUTICALS (M) SDN. BHD.
Published name
GOLD PINE BRAND BAK FONG (PIL KECIL)
Published reference
2005060633977
Registration number
MAL06021358T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL06021358T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “GOLD PINE BRAND BAK FONG (PIL KECIL)”, https://compoatlas.com/en/supplements/malaysia/MAL06021358T-gold-pine-brand-bak-fong-pil-kecil, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line